Emerald Health Therapeutics has announced that the first shipment of its own unique version of the cannabis strain, Chemdog, from its 100%-owned Richmond facility is now available through the BC Liquor Distribution Board’s online site and will become available in certain licensed cannabis retail stores in British Columbia.
"Emerald’s version of Chemdog, a sativa-dominant hybrid strain with 19-25% THC and 0-1% CBD, is the first of five unique strains that Emerald is growing and harvesting in its new Richmond, BC, operation," the team with the company explains. "Linked to Nepalese and Thai sativa landraces and crossed by US breeders during the 1970s, Chemdog is a cultivar composed of OG Kush and Sour Diesel. The sticky buds and leaves appear silver from a coating of white trichomes that give off an earthy aroma of citrus and lavender with undertones of pepper and pine."
"The design of Emerald’s Richmond growing operation allows access to the generous amount of sunshine in a natural sunbelt, while still being extremely close to key distribution and transportation hubs. The facility consists of two 78,000 square foot purpose-built greenhouses: the first one is fully licensed and now in full production; the second one is about 90% complete and should be completed by year-end. This facility employs the latest in state-of-the-art lighting and growing systems to achieve the greatest possible control and flexibility to optimize yield while also reducing environmental impact. Harvested cannabis is processed using artisanal drying, curing and trimming techniques to produce an authentic cannabis experience for its customers," they further explain.
The operation is certified by Pro-Cert Organic Systems, an accredited Canadian Food Inspection Agency, to the Canada Organic Regime. The facility is naturally growing cannabis in organic soil, which can be used over many years, is using approved organic pest management tools and fertilizers, and is on the path to produce fully organic cannabis.
“At Emerald Richmond, our skilled organic growers and operations team set out to grow some of the most challenging but appreciated strains of cannabis and deliver to discerning customers their desired product attributes. With our team’s broad expertise and care, our first harvests of Chemdog and other strains are already meeting these expectations and setting us up for multiple medical and adult-use products,” said Riaz Bandali, President & CEO, Emerald Health Therapeutics.
“Our two wholly-owned specialty facilities were purpose-built to cultivate and process premium cannabis to supply medical, adult use and organic cannabis markets. These facilities will now provide for all of our cannabis input product to serve our focus on advancing cannabis science to develop value-added products. We are already selling an acclaimed high-purity, high-CBD oil and intend to introduce new products in the next quarters. With our Richmond and St. Eustache, Quebec, facilities in full production, we are pleased about our prospect to strongly position Emerald in the premium segment of the market and for the opportunity to directly grow our sales and profit while continuing to hold a significant stake in our large-scale Pure Sunfarms joint venture, which is quickly becoming a market leader in the value segment of the Canadian cannabis market.”
For more information:
Emerald Health Therapeutics